Live Crown Castle Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

10x Genomics, Inc.

TXG

About 10x Genomics, Inc.

10x Genomics, Inc. is a life sciences technology company dedicated to advancing human health through innovative biological analysis solutions. Its key products, including the Chromium, Visium, and Xenium platforms, enable high-resolution single-cell and spatial analysis. With a $21 billion addressable market, 10x targets academic, biopharmaceutical, and research institutions. The company emphasizes R&D and customer collaboration to drive product development, aiming to enhance biological understanding and discovery across various fields.

This description was generated via AI from an annual report. Updated about 1 year ago.

Latest SEC Filings from 10x Genomics, Inc.